title: Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA?
authors.forename: H
authors.initials: H
authors.lastname: Allgayer
authors.forename: P
authors.initials: P
authors.lastname: Böhne
authors.forename: W
authors.initials: W
authors.lastname: Kruis
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003108:Colonic Diseases / Q000139:chemically induced* / Q000473:pathology; D005355:Fibrosis; D006801:Humans; D019804:Mesalamine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011350:Proctocolitis / Q000188:drug therapy*; D013488:Suppositories
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D013488:Suppositories; D019804:Mesalamine